# Comparison of Efficacy and Safety of Two Biphasic Defibrillators in Cardioversion of Atrial Fibrillation

> **NCT04032678** · NA · COMPLETED · sponsor: **University National Heart Hospital** · enrollment: 75 (actual)

## Conditions studied

- Atrial Fibrillation
- Arrythmia
- Electric Countershock

## Interventions

- **DEVICE:** Schiller Defigard Touch 7 - DGT7, Schiller Medical, France
- **DEVICE:** LIFEPAK 15, Physio-Control Inc., Redmond, WA, USA

## Key facts

- **NCT ID:** NCT04032678
- **Lead sponsor:** University National Heart Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-05
- **Primary completion:** 2020-03-30
- **Final completion:** 2020-08-06
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2020-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04032678

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04032678, "Comparison of Efficacy and Safety of Two Biphasic Defibrillators in Cardioversion of Atrial Fibrillation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04032678. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*